Dingdang Health Reports Narrowed Annual Loss of 49 Million Yuan

Stock News03-20

Dingdang Health (09886) announced its annual results for the period ended December 31, 2025. Revenue reached 4.888 billion yuan, representing a year-on-year increase of 4.7%. The loss attributable to shareholders was 49.018 million yuan, narrowing by 87.0% compared to the previous year. Basic loss per share was 0.04 yuan.

The growth in total revenue was primarily driven by an increase in revenue from the pharmaceutical and healthcare business. This segment's revenue rose by 4.5%, from 4.54 billion yuan in the year ended December 31, 2024, to 4.745 billion yuan in the year ended December 31, 2025. The improvement was attributed to the optimization of the smart pharmacy network and the expansion of the product portfolio.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1165640256?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-20 19:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1165640256","market":"other","top_or_hot":-1,"title":"Dingdang Health Reports Narrowed Annual Loss of 49 Million Yuan","media":"Stock News","content":"<p>Dingdang Health (09886) announced its annual results for the period ended December 31, 2025. Revenue reached 4.888 billion yuan, representing a year-on-year increase of 4.7%. The loss attributable to shareholders was 49.018 million yuan, narrowing by 87.0% compared to the previous year. Basic loss per share was 0.04 yuan.</p>\n<p>The growth in total revenue was primarily driven by an increase in revenue from the pharmaceutical and healthcare business. This segment's revenue rose by 4.5%, from 4.54 billion yuan in the year ended December 31, 2024, to 4.745 billion yuan in the year ended December 31, 2025. The improvement was attributed to the optimization of the smart pharmacy network and the expansion of the product portfolio.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dingdang Health Reports Narrowed Annual Loss of 49 Million Yuan</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDingdang Health Reports Narrowed Annual Loss of 49 Million Yuan\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-03-20 19:58</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Dingdang Health (09886) announced its annual results for the period ended December 31, 2025. Revenue reached 4.888 billion yuan, representing a year-on-year increase of 4.7%. The loss attributable to shareholders was 49.018 million yuan, narrowing by 87.0% compared to the previous year. Basic loss per share was 0.04 yuan.</p>\n<p>The growth in total revenue was primarily driven by an increase in revenue from the pharmaceutical and healthcare business. This segment's revenue rose by 4.5%, from 4.54 billion yuan in the year ended December 31, 2024, to 4.745 billion yuan in the year ended December 31, 2025. The improvement was attributed to the optimization of the smart pharmacy network and the expansion of the product portfolio.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09886","symbol_name":"叮当健康","start_time":0,"source_url":"","article_id":"1165640256","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1165640256","pubTimestamp":1774007896,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Dingdang Health (09886) announced its annual results for the period ended December 31, 2025. Revenue reached 4.888 billion yuan, representing a year-on-year increase of 4.7%. The loss attributable to...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"09886":"叮当健康","BK1247":"药品零售","BK1142":"互联网与直销零售"},"translate_title":"叮当健康报告年度亏损收窄4900万元","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"09886":1},"content_text":"Dingdang Health (09886) announced its annual results for the period ended December 31, 2025. Revenue reached 4.888 billion yuan, representing a year-on-year increase of 4.7%. The loss attributable to shareholders was 49.018 million yuan, narrowing by 87.0% compared to the previous year. Basic loss per share was 0.04 yuan.\nThe growth in total revenue was primarily driven by an increase in revenue from the pharmaceutical and healthcare business. This segment's revenue rose by 4.5%, from 4.54 billion yuan in the year ended December 31, 2024, to 4.745 billion yuan in the year ended December 31, 2025. The improvement was attributed to the optimization of the smart pharmacy network and the expansion of the product portfolio.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1165640256","isCrawlerRequest":true}